MARKET IS CLOSED
Loading latest tickers...

Market Indices

S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%

Sector Heatmap

Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%

EW — Edwards Lifesciences Corp

NYSE

Edwards Lifesciences Corp

CompareBack to Screener
$85.15
-0.04(-0.05%)
O
85.52
H
86.48
L
84.66
V
2.39M
⏱️ End-of-day dataAs of Oct 2, 2026

Chart

About EW

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.

IndustryORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
SectorNot available
IPO DateApr 3, 2000
Employees16,000
Stock ExchangeNYSE
Ticker SymbolEW

Key Financial Statistics

Market Cap$49.08B
P/E RatioN/A
Dividend YieldNone
EPSN/A
BetaN/A
52-Week Range$72.30 - $96.29
52-Week Avg Volume4.39M
VWAP$85.42
Transactions33,446
Total Recorded Bars6,669 days